Induction of beta‐cell resistance to hypoxia and technologies for oxygen delivery to transplanted pancreatic islets
- 3 September 2012
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 28 (6) , 475-484
Abstract
Summary: Hypoxia is believed to be a crucial factor involved in cell adaptation to environmental stress. Islet transplantation, especially with immunoisolated islets, interrupts vascular connections, resulting in the substantially decreased delivery of oxygen and nutrients to islet cells. Insulin‐producing pancreatic beta cells are known to be highly susceptible to oxygen deficiency. Such susceptibility to hypoxia is believed to be one of the main causes of beta‐cell death in the post‐transplantation period. Different strategies have been developed for the protection of beta cells against hypoxic injury and for oxygen delivery to transplanted islets. The enhancement of beta‐cell defense properties against hypoxia has been achieved using various techniques such as gene transfection, drug supplementation, co‐culturing with stem cells and cell selection. Technologies for oxygen delivery to transplanted islets include local neovascularization of subcutaneous sites, electrochemical and photosynthetic oxygen generation, oxygen refuelling of bio‐artificial pancreas and whole body oxygenation by using hyperbaric therapy. Progress in the field of oxygen technologies for islet transplantation requires a multidisciplinary approach to explore and optimize the interaction between components of the biological system and different technological processes. This review article focuses mainly on the recently developed strategies for oxygenation and protection from hypoxic injury – to achieve stable and long‐term normoglycaemia in diabetic patients with transplanted pancreatic islets. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 85 references indexed in Scilit:
- Islets Transplanted in Immunoisolation Devices: A Review of the Progress and the Challenges that RemainEndocrine Reviews, 2011
- A Novel Device for Islet Transplantation Providing Immune Protection and Oxygen SupplyHormone and Metabolic Research, 2010
- Trophic Molecules Derived From Human Mesenchymal Stem Cells Enhance Survival, Function, and Angiogenesis of Isolated Islets After TransplantationTransplantation, 2010
- Hyperbaric oxygen therapy improves early posttransplant islet functionPediatric Diabetes, 2010
- Gene expression and silencing for improved islet transplantationJournal of Controlled Release, 2009
- Islet assessment for transplantationCurrent Opinion in Organ Transplantation, 2009
- A Role for von Hippel-Lindau Protein in Pancreatic β-Cell FunctionDiabetes, 2009
- Bipartite Vector Encoding hVEGF and hIL-1Ra for ex Vivo Transduction into Human IsletsMolecular Pharmaceutics, 2008
- Coexpression of Vascular Endothelial Growth Factor and Interleukin-1 Receptor Antagonist for Improved Human Islet Survival and FunctionMolecular Pharmaceutics, 2007
- Islet cell failure in type 2 diabetesJournal of Clinical Investigation, 2006